ampicillin has been researched along with Diabetic Foot in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chow, I; Einarson, TR; Lemos, EV | 1 |
Boghossian, J; Caputo, W; Dana, A; Gray, S; Harkless, L; Pollak, R; Wu, D | 1 |
Bell-Syer, SE; Claxton, K; Craig, D; Dalton, J; Dowson, C; Gadsby, R; Golder, S; Iglesias, C; Jude, E; Nelson, EA; O'Hare, P; O'Meara, S; Powell, J | 1 |
Freeman, DV; Gibbons, GW; Grayson, ML; Habershaw, GM; Karchmer, AW; Levin, E; Pomposelli, FB; Rosenblum, BI | 1 |
Akalin, HE; Akalin, S; Akova, M; Güllü, I; Gür, D; Ozcebe, O; Telatar, F; Tokgözoglu, M; Unal, S | 1 |
Baker, PD; Fernau, R; Landon, GC; Lipsky, BA | 1 |
Abbott, TA; Berger, ML; Dasbach, EJ; Hu, XH; Markson, LE | 1 |
Kanra, G | 1 |
3 review(s) available for ampicillin and Diabetic Foot
Article | Year |
---|---|
Management and prevention of diabetic foot ulcers and infections: a health economic review.
Topics: Ampicillin; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cost-Benefit Analysis; Diabetes Complications; Diabetic Foot; Drug Combinations; Economics, Pharmaceutical; Humans; Imipenem; Quality-Adjusted Life Years; Sulbactam | 2008 |
A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers.
Topics: Ampicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Databases as Topic; Decision Support Systems, Clinical; Decision Support Techniques; Diabetic Foot; Granulocyte Colony-Stimulating Factor; Humans; Sulbactam | 2006 |
Experience with ampicillin/sulbactam in severe infections.
Topics: Ampicillin; Bacterial Infections; Brain Abscess; Diabetic Foot; Drug Therapy, Combination; Epiglottitis; Humans; Meningitis, Bacterial; Orbital Diseases; Postoperative Complications; Respiratory Tract Infections; Safety; Sulbactam; Urethritis | 2002 |
4 trial(s) available for ampicillin and Diabetic Foot
Article | Year |
---|---|
An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Diabetic Foot; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sulbactam; Time Factors; Vancomycin; Wound Infection | 2005 |
Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients.
Topics: Adult; Ampicillin; Amputation, Surgical; Bacterial Infections; Cilastatin; Combined Modality Therapy; Debridement; Diabetic Foot; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Humans; Imipenem; Osteomyelitis; Sulbactam; Treatment Outcome | 1994 |
Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; beta-Lactamase Inhibitors; Diabetic Foot; Drug Therapy, Combination; Enzyme Inhibitors; Evaluation Studies as Topic; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sulbactam; Treatment Outcome | 1996 |
Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clavulanic Acid; Clavulanic Acids; Diabetic Foot; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections, Intravenous; Male; Middle Aged; Ofloxacin; Penicillins; Prospective Studies; Sulbactam; Treatment Outcome | 1997 |
1 other study(ies) available for ampicillin and Diabetic Foot
Article | Year |
---|---|
Antibiotic therapy for foot infections in diabetics.
Topics: Ampicillin; Cilastatin; Cost-Benefit Analysis; Diabetic Foot; Drug Therapy, Combination; Foot Diseases; Humans; Imipenem; Sulbactam | 1997 |